UBS Group’s EUDA Health Holdings Warrant EUDAW Stock Holding History

UBS Group’s Portfolio EUDAW Stock Details EUDAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,201	Closed	-$129	–	10681
2025 Q3	$129	Sell	1,201 -633	-35%	-$71	﹤0.01%	9882
2025 Q2	$238	Sell	1,834 -659	-26%	-$84	﹤0.01%	9907
2025 Q1	$299	Hold	2,493	–	–	﹤0.01%	9841
2024 Q4	$277	Buy	+2,493	New	+$250	﹤0.01%	9539
2023 Q3	–	Sell	-498	Closed	-$48	–	9587
2023 Q2	$48	Sell	498 -1,566	-76%	-$161	﹤0.01%	8605
2023 Q1	$248	Sell	2,064 -2,011	-49%	-$230	﹤0.01%	9125
2022 Q4	$326	Sell	4,075 -11,596	-74%	-$3.25K	﹤0.01%	10246
2022 Q3	$7K	Buy	+15,671	New	+$5.06K	﹤0.01%	8864

Other funds holding EUDAW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

UBS Group's EUDAW Position: Q4 2025 in Review

UBS Group sold out of EUDA Health Holdings Warrant (EUDAW) in Q4 2025, closing a stake of 1,201 shares — an estimated $129 sold.

UBS Group first reported a position in EUDAW in Q3 2022 and held it in 8 quarters. The position peaked at $7K in Q3 2022. 6 funds tracked by Wall St. Rank hold EUDAW as of Q4 2025.

UBS Group reported no remaining EUDA Health Holdings Warrant position as of Q4 2025 after selling out during the quarter.
UBS Group sold 1,201 EUDA Health Holdings Warrant shares in Q4 2025, an estimated $129.
UBS Group first reported a position in EUDA Health Holdings Warrant in Q3 2022 and held it in 8 quarters.
UBS Group's EUDA Health Holdings Warrant position peaked at $7K in Q3 2022.
6 funds tracked by Wall St. Rank held EUDA Health Holdings Warrant as of Q4 2025.

Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.